In this downloadable slideset, William B. Isaacs, PhD, reviews DNA repair deficiencies in prostate cancer and their therapeutic implications.
In this downloadable slideset, Todd M. Morgan, MD, provides practical guidance on somatic and germline testing in prostate cancer, including rationale, who to test, how to test, and implications for screening/early detection and localized disease.
In this downloadable slideset, Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD, reviews the available clinical data on PARP inhibitors in advanced prostate cancer and explores how these agents may affect management strategies for patients in the near future.
In this on-demand Webcast of a CCO symposium at AUA 2018 for the practicing urologist, CCO’s expert faculty explore PARP inhibitor therapy in prostate cancer, including a review of the latest data on DNA repair deficiencies, insights into practical challenges associated with genetic testing for DNA repair defects, and a review of available clinical data on PARP inhibitors and how these agents may affect management strategies for patients in the near future.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.